TBIO
Undervalued by 1920.6% based on the discounted cash flow analysis.
Market cap | $13.13 Million |
---|---|
Enterprise Value | $28.35 Million |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-1.6 |
Beta | 1.2 |
Outstanding Shares | 30,103,284 |
Avg 30 Day Volume | 71,793 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -0.28 |
---|---|
PEG | -0.25 |
Price to Sales | - |
Price to Book Ratio | - |
Enterprise Value to Revenue | 1.03 |
Enterprise Value to EBIT | -0.81 |
Enterprise Value to Net Income | -1 |
Total Debt to Enterprise | 1.21 |
Debt to Equity | 144.45 |
No data
No data